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mThe diverse models in which graft-versus-host dis-
ase (GVHD) has been described range from in vitro
ell preparations to whole animals and, of course, to
linical experience in human beings. However, the
echanisms of the disease and the manipulation of
his reaction in favor of the patient toward a graft-
ersus-tumor effect have been persistent puzzles that
re still undergoing intensive investigation.
The difﬁcult, halting, and sometimes speculative
ask of a pathologist in both clinical and animal in vivo
ettings is to sort out this voluminous and often be-
ildering background of immunologic data to apply it
o the interpretation of histopathologic specimens.
he hope is that clinically useful conclusions can be
rawn about diagnosis and disease progression and
hat some insights into pathogenesis may result. Be-
ause inﬂammatory diseases in all organs have a lim-
ted histologic expression, pathognomonic lesions are
ot claimed. The diagnosis remains a syndromic clin-
copathologic one, even with histologic data available.
Allogeneic GVHD is deﬁned as an allograft reac-
ion of donor lymphoid cells against host histocom-
atibility antigens, minor or major. The classic basic
equirement is the engraftment of an allogeneic lym-
hoid cell population. The mechanism, which in-
olves donor T cells, cytokines, antigen-presenting
ells, and cytotoxic lymphocytes inducing damage to
arget epithelial cells, is highly complex and contro-
ersial. The key goal, which has not yet been achieved,
ould be a synthetic integration into a coherent tol-
rance model.
I chose 3 of the animal models to illustrate patho-
enetic points, with the realization that the clinical
ituation is more complicated. The cleanest in vivo
odel is the parent into F1 hybrid model, in whichhe genetics allow engraftment of the donor marrow s
B & M Tithout rejection, but the donor lymphocytes can rec-
gnize the host as foreign. Hakim [1] cites the chronic
VHD model as requiring class II disparity and CD4
ell engraftment; this produces a T-helper type 2
attern of cytokine production, with interleukin
IL)–4, IL-5, and IL-10 predominance (Table 1). Low
onor chimerism is produced, as is lymphoid hyper-
lasia with autoimmune-like phenomena, including
lomerulonephritis. This is unlike the human situa-
ion. The acute pattern requires CD4 and CD8 cells,
s well as both class I and II disparity. This yields
xtensive chimerism, replacing the host marrow and
ymphoid tissue and inducing a T-helper type 1 cyto-
ine pattern with IL-2 and interferon-, and it induces
ytotoxic lymphocytes to attack epithelial cells. This is
imilar to human acute GVHD. Over time, some of
hese animals develop a late phase similar to human
hronic GVHD with lymphoid hyperplasia and peri-
uctal lesions of the liver and salivary glands.
The syngeneic or autologous GVHD mouse model
s a special case in which true autoimmunity develops [2].
his requires an initially intact thymus, cyclosporine
dministration, and peripheral lymphoid damage, such
s irradiation. The result is the development of autocy-
otoxic CD8 lymphocytes that react against autologous
lass II antigens. A similar syndrome is seen in a small
raction of human autograft recipients.
The mouse model most closely resembling human
arrow transplantation is the model of Korngold and
prent as used by Hamilton and Parkman [3], in which
inor histoincompatible pairs are transplanted after
ost irradiation. This produces a syndrome resem-
ling human acute and chronic GVHD. The human
ituation is most analogous to this, but of course it is
ore complex, and the syndromes differ in detailomewhat [4,5].
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2The end result in human allograft recipients from
clinical and histopathologic point of view is cell
eath in the target epithelium (basal layer epithelial
amage, or apoptosis) in the skin, lip, and gut, as well
s the duct cells in the salivary glands and liver. The
nderlying damage to the lymph nodes and spleen,
ften called the lymphoid suicide reaction (perhaps better
ermed a fratricide) is basically a subclinical phenom-
non, which in the allogeneic patient persists for many
onths. The autologous patient, however, recovers
ery quickly from the lymphoid and splenic damage.
cute GVHD is a clinical triad of dermatitis gastro-
nteritis and hepatitis that occurs roughly within the
rst 50 to 80 days after transplantation and is only
asily diagnosed after chemotherapy and radiation
amage, neutropenia, and infections have recovered.
n the skin, epidermal basal cell damage with lympho-
ytic inﬁltration, spongiosis, and apoptosis are the
haracteristics of GVHD. Simultaneously, the
arafollicular bulge of the hair follicle is damaged, and
imilar lesions are seen in that structure. Sometimes
arly, but usually later, sweat ducts are also attacked
nd damaged; the combined effects produce atrophy
f most of the adnexa of the skin, especially in chronic
VHD. The lip biopsy sample, which also has a
quamous mucosa, has a similar inﬁltration of mono-
uclear cells into the basal layer with destruction of
he squamous epithelium on the surface. The minor
alivary glands are usually involved simultaneously
ith the surface epithelium, particularly the ducts of
he minor salivary glands, with the production of duct
ell apoptosis, ectasia, ﬁbrosis, and atrophy. In most of
hese sites, CD45 lymphocytes with initially a CD4
nd later a CD8 phenotype are easily identiﬁed on
mmunohistology. Later in the course of GVHD, ei-
her de novo or continuing from the acute disease,
clerodermatous lesions may develop with deep scle-
osis of the dermis, atrophy of the epidermis, com-
lete loss of the adnexa, and fasciitis, with damage to
he subcutaneous fat and the production of a sclero-
ermatous skin similar to that after eosinophilic fas-
iitis. It is thought that autologous reactivity to the
atient’s own class II antigens may be active in this
ituation. The esophagus, which is also a squamous
able 1. Differences among Chronic GVHR, Initial Phases of Acute G
odel)
Variable Chronic GVHR
onor effectors CD4
onor chimerism 4%-9%
onor cytokines IL-4, IL-10
utoantibodies Yes
hymic alterations No
uppression of B- and T-cell responses No
VHR, graft-versus-host reaction; NK, natural killer; IL, interleukrgan, is inﬁltrated similarly to the skin and lip with 3
2nﬁltrating lymphocytes and apoptotic cells. The small
ntercalated bile ducts of the liver are prime targets in
VHD in most species examined, including mice,
umans, horses, dogs, and nonhuman primates. This
ay be a result of the oval cell stem localization
round the small bile ducts in the liver. The gastro-
ntestinal tract, which is usually the cause of death in
cute GVHD, is attacked in stem cell regions of the
rypts near the necks of crypts with apoptotic cells,
hich may be present in single or multiple examples
ith lymphocytes and occasional eosinophils. Crypt
amage, crypt loss, and even denudation of the epi-
helium with fatal bleeding or sepsis may follow. In
he lung, acute GVHD remains controversial, but
hronic GVHD clearly shows bronchiolitis obliterans
nd an association with bronchiolitis obliterans orga-
izing pneumonia. Chronic GVHD may also show
ome infrequent manifestations such as myositis, se-
ositis, arthritis, and autoantibodies. One of the key
anifestations of chronic GVHD is, in addition to dry
outh, dry eyes, with an attack on the lacrimal glands
nd corneal epithelium identical to the lesions seen in
alivary glands. These lesions can produce severe
eratoconjuctivitis sicca and induce immune deﬁ-
iency, thus allowing various conjunctival and scleral
nfections, especially herpes simplex. Emphasis in this
alk will be placed on the hypothesis that the epithelial
tem cell domains in the affected organs in GVHD
omprise a common target region because of the pres-
nce of the proliferation of transient amplifying cells
n the stem cell regions, such as the epidermal rete
idges, the parafollicular bulges, the crypts of the gut,
he small bile ducts of the liver, and the ﬁliform
apillae of the tongue [6].
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nd Long-Term Acute GVHR (After Hakim [1]; Parent to F1 Hybrid
cute GVHR Initial Phase Acute GVHR Long Term
CD4, CD8, NK ND (CD4 and CD8 in humans)
95% 95%
IL-2, IFN-, TNF IL-4
No ND (yes in fraction of humans)
Yes No (yes in humans)
Yes No (yes in humans)
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